Precision Health Clinical Trials
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
Conditions: Hematopoietic and Lymphoid System Neoplasm; Metastatic Malignant Solid Neoplasm
Interventions: Procedure: Biopsy Specimen; Procedure: Biospecimen Collection; Other: Medical Chart Review
Sponsor: Mayo Clinic
Recruiting
Interventions: Procedure: Biopsy Specimen; Procedure: Biospecimen Collection; Other: Medical Chart Review
Sponsor: Mayo Clinic
Recruiting
For more information, visit the Study URL.
Detection of Tumor DNA Through Cervical Smear and Liquid Biopsy in Endometrial Cancer Patients and Evaluation of Prognostic and Predictive Values of Tumor DNA Assay
Condition: Endometrial Cancer
Intervention:
Sponsor: Yonsei University
Recruiting
Intervention:
Sponsor: Yonsei University
Recruiting
For more information, visit the Study URL.
Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression
Condition: Psychiatric Disorder
Intervention: Genetic: study of the transmission of genetic variants
Sponsor: Fondation FondaMental
Not yet recruiting
Intervention: Genetic: study of the transmission of genetic variants
Sponsor: Fondation FondaMental
Not yet recruiting
For more information, visit the Study URL.
'Lung Health Check' Biomarker Study
Conditions: Lung Cancer; Cancer
Intervention: Diagnostic Test: Blood Specimen
Sponsors: Royal Marsden NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; Royal Marsden Partners Cancer Alliance
Recruiting
Intervention: Diagnostic Test: Blood Specimen
Sponsors: Royal Marsden NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; Royal Marsden Partners Cancer Alliance
Recruiting
For more information, visit the Study URL.
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC
Condition: Breast Cancer Recurrent
Intervention: Other: Functional Precision Oncology
Sponsors: University of Utah; United States Department of Defense
Recruiting
Intervention: Other: Functional Precision Oncology
Sponsors: University of Utah; United States Department of Defense
Recruiting
For more information, visit the Study URL.
THIO Sequenced With Cemiplimab in Advanced NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: 6-Thio-2'-Deoxyguanosine; Drug: Cemiplimab
Sponsor: Maia Biotechnology
Recruiting
Interventions: Drug: 6-Thio-2'-Deoxyguanosine; Drug: Cemiplimab
Sponsor: Maia Biotechnology
Recruiting
For more information, visit the Study URL.
Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy
Condition: H Pylori Infection
Interventions: Genetic: detection of vacuolating cytotoxin A (Vac A) and cytotoxin-associated gene A (Cag A) virulent H.Pylori genotypes by polymerase chain reaction amplification(PCR) in gastric biopsies :; Diagnostic Test: Culture and sensitivity of endoscopic gastric biopsies:; Other: Histopathological examination endoscopic gastric biopsies:; Procedure: Upper endoscopy; Drug: empirical H.pylori regimens; Diagnostic Test: H.Pylori Ag in stool
Sponsor: Assiut University
Not yet recruiting
Interventions: Genetic: detection of vacuolating cytotoxin A (Vac A) and cytotoxin-associated gene A (Cag A) virulent H.Pylori genotypes by polymerase chain reaction amplification(PCR) in gastric biopsies :; Diagnostic Test: Culture and sensitivity of endoscopic gastric biopsies:; Other: Histopathological examination endoscopic gastric biopsies:; Procedure: Upper endoscopy; Drug: empirical H.pylori regimens; Diagnostic Test: H.Pylori Ag in stool
Sponsor: Assiut University
Not yet recruiting
For more information, visit the Study URL.
BioMEL- Diagnostic and Prognostic Factors in Melanoma.
Conditions: Melanoma; Melanoma in Situ; Dysplastic Nevi; Mole (Dermatology); Image; Mutation
Intervention: Diagnostic Test: Imaging
Sponsor: Region Skane
Recruiting
Intervention: Diagnostic Test: Imaging
Sponsor: Region Skane
Recruiting
For more information, visit the Study URL.
Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working
Conditions: Locally Advanced Leiomyosarcoma; Locally Advanced Uterine Corpus Leiomyosarcoma; Metastatic Leiomyosarcoma; Metastatic Uterine Corpus Leiomyosarcoma; Stage III Uterine Corpus Leiomyosarcoma AJCC v8; Stage IV Uterine Corpus Leiomyosarcoma AJCC v8; Unresectable Leiomyosarcoma; Unresectable Uterine Corpus Leiomyosarcoma; Uterine Corpus Leiomyosarcoma
Interventions: Drug: Olaparib; Drug: Pazopanib; Drug: Temozolomide; Drug: Trabectedin
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
Interventions: Drug: Olaparib; Drug: Pazopanib; Drug: Temozolomide; Drug: Trabectedin
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
For more information, visit the Study URL.
Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers
Conditions: Esophageal Cancer; Gastric (Stomach) Cancer; Colorectal Cancer; Hepatocellular Carcinoma
Intervention:
Sponsors: Singlera Genomics Inc.; Fudan University; Shanghai Public Health Clinical Center; Xuhui Central Hospital, Shanghai; Shanghai Zhongshan Hospital
Recruiting
Intervention:
Sponsors: Singlera Genomics Inc.; Fudan University; Shanghai Public Health Clinical Center; Xuhui Central Hospital, Shanghai; Shanghai Zhongshan Hospital
Recruiting
For more information, visit the Study URL.